Safe Use of Platelet Concentrate in Blood Service Institutions


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The efficiency of modern equipment providing the safe use of platelet concentrate (PC) in blood service institu-tions was studied. In 2013, 63.5% of the total amount of PC used in the domestic blood service was obtained by apheresis (from region to region, this value varied from 52.4 to 79.2%). For the period from 2011 to 2013, the percentage of leukoreduced platelets in the PC composition increased by 1.3 times, while the percentage of pathogen-inactivated PC increased by 3.8 times.

作者简介

A. Chechetkin

Russian Scientific Research Institute of Hematology and Blood Transfusion, Federal Medical-Biological Agency

Email: ooo.giperion@gmail.com
俄罗斯联邦, St. Petersburg

V. Danilchenko

Russian Scientific Research Institute of Hematology and Blood Transfusion, Federal Medical-Biological Agency

Email: ooo.giperion@gmail.com
俄罗斯联邦, St. Petersburg

M. Grigoryan

Russian Scientific Research Institute of Hematology and Blood Transfusion, Federal Medical-Biological Agency

Email: ooo.giperion@gmail.com
俄罗斯联邦, St. Petersburg

A. Makeev

Russian Scientific Research Institute of Hematology and Blood Transfusion, Federal Medical-Biological Agency

Email: ooo.giperion@gmail.com
俄罗斯联邦, St. Petersburg

A. Gudkov

NPI Firma Giperion, Ltd.

编辑信件的主要联系方式.
Email: ooo.giperion@gmail.com
俄罗斯联邦, Moscow

S. Shchukin

Bauman Moscow State Technical University

Email: ooo.giperion@gmail.com
俄罗斯联邦, Moscow

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media New York, 2016